Amanda L. Hayward, Ph.D.
Amanda works closely with the Venture Team managing venture and equity investments out of CI’s life science investment funds. An experienced life science–focused executive, Amanda spent more than 17 years in venture capital, corporate strategy, business development, company formation and early-stage operations.
Amanda was most recently at Baxalta/Shire, where she was a partner on the Ventures team, making equity investments out of a $200M strategic fund focused on areas of interest to Baxalta. Prior to Baxalta, Amanda was senior vice president at Scheer and Company, Inc., where she co-founded and helped manage a number of startup companies within the context of Scheer’s venture origination practice, in addition to providing high-level strategic, business development and transaction advice to life science companies, entrepreneurs and investors.
Prior to Scheer, Amanda was the Bristol Myers Squibb Life Sciences Research Foundation postdoctoral scholar at Yale University, where her research focused on understanding molecular mechanisms contributing to cardiovascular disease.
In addition to her role at CI, Amanda consults for a variety of companies and venture funds in the life science space. She is also executive chairman of Hoba Therapeutics, a venture-backed startup company based in Copenhagen, Denmark. She lives in Killingworth, Connecticut, with her two children.